Moli1901 duramycin: MLCM began a U.S. Phase II trial of Moli1901 in CF patients. The company said the trial will assess the delivery and deposition of the compo

MoliChem Medicines Inc. (MLCM), Chapel Hill, N.C. Product: Moli1901 duramycin (2622U90) Business: Pulmonary Therapeutic category: Ion channel modulation Target: Chloride channels Description: Pulmona...